Rajiv Radhakrishnan MD
Associate Professor of Psychiatry, and of Radiology and Biomedical Imaging at Yale School of Medicine
Join to View Full Profile
300 George StSuite 901New Haven, CT 06511
Dr. Radhakrishnan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rajiv Radhakrishnan is a psychiatrist based in New Haven, CT, who completed his residency in psychiatry at Yale-New Haven Medical Center in 2016 after graduating from Yale School of Medicine. His research includes multiple publications focused on psychiatric topics, notably involving schizophrenia, autism, bipolar depression, and substance use. Among his recent works, he explores cognitive functions in women with schizophrenia, synaptic density in autism, and treatment efficacy in bipolar depression. Dr. Radhakrishnan is also involved in several clinical trials, acting as a principal investigator in studies on synaptic density and treatment of schizophrenia, further underlining his active engagement in advancing psychiatric research.
Education & Training
Yale-New Haven Medical CenterResidency, Psychiatry, 2012 - 2016
Yale School of MedicineClass of 2016
Certifications & Licensure
CT State Medical License 2014 - 2026
American Board of Psychiatry and Neurology Psychiatry
American Board of Preventive Medicine Addiction Medicine
Clinical Trials
- D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia Start of enrollment: 2002 Sep 01
- SV2A in Older Adults Start of enrollment: 2022 Jul 06
Roles: Contact, Principal Investigator
- SV2 PET Imaging With [11C]APP311 Start of enrollment: 2017 Dec 01
Roles: Contact
Publications & Presentations
PubMed
- 2 citationsExceptional brain PET images from the NeuroEXPLORER: scans with targeted radiopharmaceuticals and comparison to HRRT.Tommaso Volpi, Takuya Toyonaga, Nikkita Khattar, Jean-Dominique Gallezot, Mika Naganawa
European Journal of Nuclear Medicine and Molecular Imaging. 2026-02-01 - 4 citationsCarotid Artery Image-Derived Blood Time-Activity Curves on the NeuroEXPLORER: Initial Multitracer Validation Against Arterial Sampling.Tommaso Volpi, Jean-Dominique Gallezot, Shannan Henry, Mark Dias, Nikkita Khattar
Journal of Nuclear Medicine. 2025-12-03 - Measuring Dopamine Transporter Availability and Synaptic Density in Parkinson's Disease: A Dual-Tracer Positron Emission Tomography Imaging Study.Faranak Ebrahimian Sadabad, Tommaso Volpi, Praveen Honhar, Sule Tinaz, Mark Dias
Movement Disorders. 2025-12-01
Journal Articles
- A systematic review of approaches to improve medication adherence in homeless populations with psychiatric disordersRachel Hird, Rajiv Radhakrishnan, Jack Tsai, Frontiers in Psychiatry, 12/19/2023
Books/Book Chapters
Press Mentions
This Is Your Brain on Legal Drugs: Let’s End the Drug War with a Minimum of Casualties by Following the ScienceJuly 29th, 2014
Cannabis Use and Psychotic DisordersMarch 19th, 2020
Grant Support
- Do hippocampal synaptic density deficits in cannabis use disorder improve following abstinence?YALE UNIVERSITY2021–2026
- Impact of cannabis legalization on prescription drug use and health outcomes in ConnecticutYALE UNIVERSITY2023–2025
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)YALE UNIVERSITY2019–2024
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)YALE UNIVERSITY2019–2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
